"> Life Insurance with Multiple Sclerosis | MS Life Insurance | High Risk - Term Insurance Brokers
Get covered in as little as 24 hours Trusted by thousands of families nationwide
Call Free: 1-888-972-0024

Life Insurance with Multiple Sclerosis | MS Life Insurance | High Risk

Multiple sclerosis (MS) is one of the more complex neurological conditions in life insurance underwriting because outcomes vary so dramatically based on disease type and progression. Relapsing-remitting MS (RRMS) with infrequent relapses and minimal disability may qualify for coverage at a table rating; progressive forms of MS with significant disability typically result in decline at standard carriers. MS type, relapse frequency, functional disability level, and current treatment are the variables that drive everything.

What Underwriters Evaluate for Multiple Sclerosis

Every MS case is reviewed individually. These are the factors that determine whether you qualify, at what rating, and with which carrier:

MS Type — Relapsing-remitting MS (RRMS) is viewed most favorably, particularly when relapses are infrequent and well-controlled on disease-modifying therapy. Secondary progressive MS (SPMS) and primary progressive MS (PPMS) typically result in decline at most standard carriers due to the progressive nature of disability.
Relapse Frequency — The number of relapses in the past 2–5 years is a key metric. No relapses in the past 2 years with stable MRI is viewed most favorably. Frequent relapses (2+ per year) significantly worsen the underwriting outcome regardless of recovery.
Functional Disability Level (EDSS Score) — The Expanded Disability Status Scale (EDSS) is referenced by many underwriters. EDSS of 0–3 (minimal to moderate disability, fully ambulatory) is most insurable. EDSS of 4–5 (moderate disability, some walking limitation) results in table ratings or decline. EDSS above 5 typically results in decline at standard carriers.
Current Treatment and Compliance — Active use of FDA-approved disease-modifying therapies (DMTs) such as interferons, natalizumab, or ocrelizumab is viewed positively. It demonstrates engagement with treatment and potentially better disease control. Non-treatment or non-compliance raises concern.
Age at Diagnosis and Duration — Earlier age of onset and longer disease duration with minimal progression is viewed favorably — it suggests a more benign disease course. Recent diagnosis requires a waiting period at most carriers to assess stability.

MS Profile: General Underwriting Outlook

MS Profile Typical Rating Best Achievable Notes
RRMS, no relapses 2+ years, EDSS 0–2 Table 4–6 Table 4 at select carriers Most favorable MS presentation; stable and minimal disability
RRMS, 1–2 relapses in past 3 years, EDSS 2–3 Table 6–8 Table 6 at competitive carriers Active but mild disease; limited options
RRMS, frequent relapses or EDSS 4+ Decline at most carriers Simplified or guaranteed issue Significant disability or active disease limits options severely
Progressive MS (SPMS or PPMS) Decline Guaranteed issue only Progressive forms are declined at virtually all standard carriers

Guidelines current as of 2025–2026. Verify with us before applying.

Situations That Typically Result in Decline

Progressive MS (SPMS or PPMS) — Any progressive form of MS results in decline at virtually all fully underwritten carriers. The inherent progressive nature of disability makes standard coverage unavailable. Guaranteed issue products remain an option.
Significant Functional Disability (EDSS 5+) — Moderate to severe disability, particularly impaired ambulation requiring aids, results in decline at most standard carriers regardless of MS type.
Frequent Recent Relapses — Multiple relapses within the past 12–24 months signal active, poorly controlled disease and result in postponement or decline at most carriers until a period of stability is established.

What You Can Do to Improve Your Outcome

Stay current with disease-modifying therapy. Active treatment demonstrates engagement and potentially better disease control. Carriers view compliant, treated MS more favorably than untreated disease.
Apply during a period of documented stability. A relapse-free period of 12–24 months with stable MRI findings is the single most important factor in improving your underwriting outcome. Timing your application strategically makes a significant difference.
Work with a broker who knows MS underwriting. The spread between the most and least competitive carrier for MS can be several table ratings or the difference between insurable and declined. Informal shopping before formal application is essential.

Have MS? Let’s Find Your Coverage Options.

MS underwriting is highly carrier-dependent. We identify which carriers are most competitive for your specific disease profile before any formal application is submitted.

Call 1-888-972-0024

Browse All High-Risk Conditions

Atrial Fibrillation | Heart Attack / Heart Disease | High Blood Pressure | Stroke / TIA | Diabetes | Obesity | Thyroid Disease | COPD / Emphysema | Sleep Apnea | Lupus | Rheumatoid Arthritis | Kidney Disease (CKD) | Hepatitis B & C | Crohn’s Disease | Ulcerative Colitis | Cancer History | Anxiety / Depression | Bipolar Disorder | Epilepsy | PTSD | HIV / AIDS | DUI / DWI | Drug Use / Abuse | Marijuana Use | Aviation / Pilots

Understanding Your Rating: Life Insurance Risk Classifications | Table Ratings Explained (B–J) | Flat Extra Ratings

Authoritative Resources: Life insurance underwriting practices are regulated by the NAIC. Insurers may check your health history through the MIB Group — you can request your free annual MIB report at mib.com.

Ready to Protect What Matters Most?

Get your free, no-obligation quote in under 60 seconds. Our advisors are available 7 days a week, 9am–9pm.

Get My Free Quote Call 1-888-972-0024